146 related articles for article (PubMed ID: 16884897)
21. [A preliminary clinical observation of giant cell tumor of bone treated by adriamycin-loaded chitosan drug delivery system].
Zhang Y; Hou C; Chen A
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 1998 Sep; 12(5):280-2. PubMed ID: 10437104
[TBL] [Abstract][Full Text] [Related]
22. Polybutylcyanoacrylate magnetic nanoparticles as carriers of adriamycin.
Cai L; Niu G; Hu Z; Jin W; Wang J; Sun L
J Drug Target; 2009 Apr; 17(3):200-6. PubMed ID: 19558359
[TBL] [Abstract][Full Text] [Related]
23. Cellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicin.
Hu FQ; Wu XL; Du YZ; You J; Yuan H
Eur J Pharm Biopharm; 2008 May; 69(1):117-25. PubMed ID: 17997293
[TBL] [Abstract][Full Text] [Related]
24. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery.
Lin A; Liu Y; Huang Y; Sun J; Wu Z; Zhang X; Ping Q
Int J Pharm; 2008 Jul; 359(1-2):247-53. PubMed ID: 18457928
[TBL] [Abstract][Full Text] [Related]
25. Review paper: chitosan derivatives as promising materials for controlled drug delivery.
Prabaharan M
J Biomater Appl; 2008 Jul; 23(1):5-36. PubMed ID: 18593819
[TBL] [Abstract][Full Text] [Related]
26. [Research on carboxymethyl chitosan acting as the adjuvant for implantable degradable microspheres].
Yin C; Hou C; Jiang L; Gu Q
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):350-4. PubMed ID: 15250131
[TBL] [Abstract][Full Text] [Related]
27. [Preparation and release exam of magnetic chitosan nano-spheres of doxorubicin].
Han T; Xiao Q; Zhang Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Feb; 27(1):86-90. PubMed ID: 20337031
[TBL] [Abstract][Full Text] [Related]
28. Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity.
Hyung Park J; Kwon S; Lee M; Chung H; Kim JH; Kim YS; Park RW; Kim IS; Bong Seo S; Kwon IC; Young Jeong S
Biomaterials; 2006 Jan; 27(1):119-26. PubMed ID: 16023198
[TBL] [Abstract][Full Text] [Related]
29. [Novel biodegradable materials for drug delivery systems (DDS)].
Sugitachi A; Kashiwaba M; Shimada Y; Terashima M; Asahi H; Saitoh K; Yoshida Y
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1530-3. PubMed ID: 11707972
[TBL] [Abstract][Full Text] [Related]
30. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS
Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871
[TBL] [Abstract][Full Text] [Related]
31. Release behavior of amoxicillin from glycol chitosan superporous hydrogels.
Park J; Kim D
J Biomater Sci Polym Ed; 2009; 20(5-6):853-62. PubMed ID: 19323894
[TBL] [Abstract][Full Text] [Related]
32. Novel drug carrier--chitosan gel microspheres with covalently attached nicotinic acid.
Szczubialka K; Zomerska K; Karewicz A; Nowakowska M
J Control Release; 2006 Nov; 116(2):e13-5. PubMed ID: 17718945
[No Abstract] [Full Text] [Related]
33. Sustained insulin release with biodegradation of chitosan gel beads prepared by copper ions.
Kofuji K; Murata Y; Kawashima S
Int J Pharm; 2005 Oct; 303(1-2):95-103. PubMed ID: 16139972
[TBL] [Abstract][Full Text] [Related]
34. A chitosan-dipotassium orthophosphate hydrogel for the delivery of Doxorubicin in the treatment of osteosarcoma.
Ta HT; Dass CR; Larson I; Choong PF; Dunstan DE
Biomaterials; 2009 Jul; 30(21):3605-13. PubMed ID: 19345993
[TBL] [Abstract][Full Text] [Related]
35. Preparation and characterization of N-succinyl-N'-octyl chitosan micelles as doxorubicin carriers for effective anti-tumor activity.
Xiangyang X; Ling L; Jianping Z; Shiyue L; Jie Y; Xiaojin Y; Jinsheng R
Colloids Surf B Biointerfaces; 2007 Apr; 55(2):222-8. PubMed ID: 17254755
[TBL] [Abstract][Full Text] [Related]
36. Enzyme-responsive release of encapsulated proteins from biodegradable hollow capsules.
Itoh Y; Matsusaki M; Kida T; Akashi M
Biomacromolecules; 2006 Oct; 7(10):2715-8. PubMed ID: 17025343
[TBL] [Abstract][Full Text] [Related]
37. [Review on progress of research on drug releasing mechanism of chitosan microspheres].
Li J; Zou Q; Lai X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Aug; 28(4):843-6. PubMed ID: 21936393
[TBL] [Abstract][Full Text] [Related]
38. Biodegradable chitosan scaffolds containing microspheres as carriers for controlled transforming growth factor-beta1 delivery for cartilage tissue engineering.
Cai DZ; Zeng C; Quan DP; Bu LS; Wang K; Lu HD; Li XF
Chin Med J (Engl); 2007 Feb; 120(3):197-203. PubMed ID: 17355821
[TBL] [Abstract][Full Text] [Related]
39. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
Wong HL; Rauth AM; Bendayan R; Wu XY
Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986
[TBL] [Abstract][Full Text] [Related]
40. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.
Zhang J; Chen XG; Li YY; Liu CS
Nanomedicine; 2007 Dec; 3(4):258-65. PubMed ID: 17962086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
